Literature DB >> 20652831

Clinical value of blood pressure measurement in the community pharmacy.

Daniel Sabater-Hernández1, Inés Azpilicueta, Pablo Sánchez-Villegas, Pedro Amariles, María I Baena, María J Faus.   

Abstract

AIM OF THE STUDY: To investigate whether the measurement of blood pressure in the community pharmacy is a valuable method to diagnose hypertension, to assess the need and the effectiveness of anti-hypertensive treatments, or, in general, to make clinical decisions.
METHOD: Information has been extracted from articles published in English and in Spanish, from January 1989 to December 2009, in indexed magazines in MEDLINE and EMBASE. To perform the search, multiple and specified terms related to the community pharmacy setting, to blood pressure measurement and to the comparison and agreement between blood pressure measurement methods were used. Selected articles were those that: (1) compared and/or measured the agreement (concordance) between community pharmacy blood pressure measurements obtained in repeated occasions, or (2) compared and/or measured the agreement between the community pharmacy blood pressure measurement method and other measurement methods used in clinical practice for decision-making purposes: blood pressure measurement by a physician, by a nurse and home or ambulatory blood pressure monitoring. Articles were included and analyzed by two investigators independently, who essentially extracted the main results of the manuscripts, emphasizing the assessment of the blood pressure measurement methods used and the completed statistical analysis.
RESULTS: Only three studies comparing the community pharmacy blood pressure measurement method with other methods and one comparing repeated measurements of community pharmacy blood pressure were found. Moreover, these works present significant biases and limitations, both in terms of method and statistical analysis, which make difficult to draw consistent conclusions.
CONCLUSION: Further research of high quality is needed, which results can guide the clinical decision-making based on the community pharmacy blood pressure measurement method.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652831     DOI: 10.1007/s11096-010-9419-4

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  18 in total

Review 1.  [Statistical approaches to evaluate agreement].

Authors:  Josep Lluís Carrasco; Lluís Jover
Journal:  Med Clin (Barc)       Date:  2004       Impact factor: 1.725

2.  [Self-measurement of blood pressure. Consensus Paper Spain 2007].

Authors:  A Coca; V Bertomeu; A Dalfó; E Esmatjes; F Guillén; L Guerrero; J L Llisterri; R Marín-Iranzo; C Megía; L Rodríguez-Mañas; C Suárez
Journal:  Rev Clin Esp       Date:  2007-04       Impact factor: 1.556

3.  Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme.

Authors:  T Karwalajtys; J Kaczorowski; B Hutchison; M G Myers; S M Sullivan; L W Chambers; L Lohfeld
Journal:  J Hum Hypertens       Date:  2009-01-22       Impact factor: 3.012

Review 4.  What is the white-coat effect and how should it be measured?

Authors:  Thomas G Pickering; William Gerin; Amy R Schwartz
Journal:  Blood Press Monit       Date:  2002-12       Impact factor: 1.444

5.  Opportunities and responsibilities in pharmaceutical care.

Authors:  C D Hepler; L M Strand
Journal:  Am J Hosp Pharm       Date:  1990-03

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  White coat effect and white coat hypertension in community pharmacy practice.

Authors:  Andrea Botomino; Benedict Martina; Dominique Ruf; Rudolf Bruppacher; Kurt E Hersberger
Journal:  Blood Press Monit       Date:  2005-02       Impact factor: 1.444

8.  [The ZANyCONTROL study. The role of the pharmacy].

Authors:  J Abellán Alemán; V Gil Guillén; J Merino Sánchez; J L Llisterri Caro; M Leal Hernández
Journal:  Rev Clin Esp       Date:  2008-11       Impact factor: 1.556

Review 9.  [Usefulness of ambulatory blood pressure monitoring for clinical decisions making].

Authors:  Daniel Sabater-Hernández; Oussamah Fikri-Benbrahim; María José Faus
Journal:  Med Clin (Barc)       Date:  2009-10-12       Impact factor: 1.725

10.  Hypertensive patients' use of blood pressure monitors stationed in pharmacies and other locations: a cross-sectional mail survey.

Authors:  Anthony J Viera; Lauren W Cohen; C Madeline Mitchell; Philip D Sloane
Journal:  BMC Health Serv Res       Date:  2008-10-22       Impact factor: 2.655

View more
  3 in total

1.  Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study.

Authors:  Daniel Sabater-Hernández; Pablo Sánchez-Villegas; José P García-Corpas; Pedro Amariles; José Sendra-Lillo; María J Faus
Journal:  Int J Clin Pharm       Date:  2011-04-27

2.  Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.

Authors:  Daniel Sabater-Hernández; Alejandro De La Sierra; Pablo Sánchez-Villegas; Fidelina M Santana-Pérez; Luisa Merino-Barber; María J Faus
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-05       Impact factor: 3.738

Review 3.  A comparison of blood pressure in community pharmacies with ambulatory, home and general practitioner office readings: systematic review and meta-analysis.

Authors:  Ali Albasri; Jack W OʼSullivan; Nia W Roberts; Suman Prinjha; Richard J McManus; James P Sheppard
Journal:  J Hypertens       Date:  2017-10       Impact factor: 4.844

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.